Most of the tumors in the throat, base of the tongue, and tonsils are difficult to reach for surgical treatment. However, advancement in technology has made it possible to perform these surgeries through the use of robotic technology. This type of surgery allows for the surgeon to sit at a distance at a remote-control console and performs the surgery by controlling the robot which will be executing the surgery on the patient. While the robotic hands execute the surgery, it is the surgeon who is in complete control of the procedure.
Transoral robotic surgery is a procedure to remove mouth and throat cancers in which a surgeon uses a sophisticated, computer-enhanced system to guide the surgical tools.
Transoral robotic surgery gives the surgeon an enhanced view of the cancer and surrounding tissue. Using a robotic system to guide the surgical tools allows for more-precise movements in tiny spaces and the capability to work around corners.
When compared with more-traditional procedures, transoral robotic surgery tends to result in a quicker recovery and fewer complications for people with mouth and throat cancers
head and neck cancer.
TORS is an innovative, minimally invasive treatment option to remove head and neck cancers through the mouth, especially those related to the human papilloma virus (HPV). Traditionally, surgeons have had to remove these cancers with more invasive approaches (such as by splitting the jaw or throat) that result in longer healing times and more side effects. TORS can help patients achieve a quicker recovery and potentially better functional outcomes.
Surgeons at the University of Chicago Medicine are proficient in using TORS to remove head and neck cancers. During TORS, surgeons use precision robotic arms and high-resolution cameras that allow them to work with greater accuracy in small, difficult-to-reach areas, such as the back of the tongue (tongue base).
UChicago Medicine is one of only a few hospitals in the Chicago area that offers TORS to head and neck cancer patients. Our surgeons are specially trained in this advanced technique and understand which patients are the best candidates for TORS.
Additionally, UChicago Medicine is the only hospital in the Chicago region to offer TORS in conjunction with immunotherapy as a treatment for head and neck cancer, potentially avoiding the need to undergo traditional radiation and chemotherapy.
Traditional surgery to remove certain head and neck cancers may require an incision through the throat or the need to split the jawbone. With TORS, surgeons can remove selected tumors through the patient’s mouth. This offers the following benefits:
Depending on the extent of their cancer, some patients may be able to avoid the need for full-dose radiation or chemotherapy after TORS.
You may be a candidate for TORS if you have one of the following cancers:
Our internationally recognized head and neck cancer team carefully evaluates each patient to determine if TORS is the best option. This multidisciplinary team includes head and neck surgeons, radiation oncologists, medical oncologists, pathologists, radiologists and speech and language pathologists.
At UChicago Medicine, our patients benefit from our extensive experience treating the entire range of head and neck cancer cases. Our head and neck cancer team pioneered, co-developed or first implemented many innovations for this disease in the Chicago area.
Many patients have head and neck cancers that have spread from an unknown site in the body. Traditionally, these patients have received full-dose radiation therapy for their cancer. This can have serious side effects, including temporary and chronic issues with speech, swallowing, dry mouth and altered taste.
Using the TORS approach, surgeons often can identify the primary source of these cancers. Then surgeons can either remove the primary tumor or enable radiation oncologists to provide more targeted radiation at lower doses. This helps reduce the risk of speech and swallowing problems.
During TORS, the surgeon sits at a control panel in the operating room while the patient is nearby on the operating table. The control panel has a screen that shows 3D, high-resolution images of the patient’s tumor and surrounding tissues. The panel also includes controls that allow the surgeon to operate the robotic instruments to remove the tumor.
The robotic arms have instruments that allow for greater flexibility and range of movement. They also are tremor free compared with a surgeon’s hands.
Following TORS, patients recover in the state-of-the-art Center for Care and Discovery on the University of Chicago Medicine campus. Patients may have a temporary feeding tube through their nose to provide additional nutrition. The day after the operation, patients typically can swallow liquids. A speech and swallowing specialist may teach strategies to make swallowing easier after surgery. A few days after TORS, most patients are able to advance to a soft diet.
Patients with head and neck cancer require close follow-up care after TORS. This includes regular visits with the head and neck cancer team for cancer surveillance. Some patients with early stage cancers may not require chemotherapy or radiation after TORS. Others may require chemotherapy, radiation or both.
Throughout the patient’s treatment, our goal is to provide effective, compassionate and patient-centered care.
Dear All
In view of the COVID 19 attack, we at Suman Clinic want to initiate online consults which will benefit our patient’s Consultants available for online consultation except for Sundays.
Steps to follow
